Results 321 to 330 of about 143,193 (344)
Some of the next articles are maybe not open access.
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Ca-A Cancer Journal for Clinicians, 2022Paolo Tarantino +2 more
exaly
Cancer epigenetics in clinical practice
Ca-A Cancer Journal for Clinicians, 2023Veronica Davalos, Manel Esteller
exaly
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020Vaibhav G Patel +2 more
exaly
Suspected Drug-Induced Hepatic Reactions Reported to the FDA's Adverse Reaction System: An Overview [PDF]
Seminars in Liver Disease, 1981 openaire +2 more sources
[Reporting system for adverse drug reactions and infections].
Nihon rinsho. Japanese journal of clinical medicine, 2008Masayuki, Hashiguchi, Mayumi, Mochizuki
openaire +2 more sources
An update on the immune landscape in lung and head and neck cancers
Ca-A Cancer Journal for Clinicians, 2020Jennifer W Carlisle, Nabil F Saba
exaly
Evolving standards of care and new challenges in the management of HER2‐positive breast cancer
Ca-A Cancer Journal for Clinicians, 2020Grace M Choong +2 more
exaly
Innovations in research and clinical care using patient‐generated health data
Ca-A Cancer Journal for Clinicians, 2020Aasha I Hoogland +2 more
exaly
Current recommendations and recent progress in endometrial cancer
Ca-A Cancer Journal for Clinicians, 2019Gini F Fleming
exaly